Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta

被引：7

作者：

Mayorga, C

Luque, G

Romero, F

Guerrero, R

Blanca, M

Fernandez, O ^{[1
]}

机构：

[1] Carlos Haya Hosp, Neurol Serv, E-29010 Malaga, Spain

[2] Carlos Haya Hosp, Res Unit, E-29010 Malaga, Spain

来源：

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 1999年 / 118卷 / 2-4期

关键词：

multiple sclerosis; interferon-beta; neutralizing antibody;

D O I：

10.1159/000024139

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：368 / 371

页数：4

共 4 条

[1]

ARNASON B, 1997, INT MS J, V4, P40

[2]

Duquette P, 1996, NEUROLOGY, V47, P889

[3] Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis [J].

Rudick, RA ;

Simonian, NA ;

Alam, JA ;

Campion, M ;

Scaramucci, JO ;

Jones, W ;

Coats, ME ;

Goodkin, DE ;

Weinstock-Guttman, B ;

Herndon, RM ;

Mass, MK ;

Richert, JR ;

Salazar, AM ;

Munschauer, FE ;

Cookfair, DL ;

Simon, JH ;

Jacobs, LD .

NEUROLOGY, 1998, 50 (05) :1266-1272

[4] Anti-cytokine autoantibodies: Epiphenomenon or critical modulators of cytokine action [J].

vanderMeide, PH ;

Schellekens, H .

BIOTHERAPY, 1997, 10 (01) :39-48

← 1 →